Oovacha offers Reveal Clinical, an AI‑driven platform that integrates a company’s trial data with published literature and real‑world evidence to simulate alternative trial designs and forecast subgroup‑level clinical and commercial outcomes. By running model‑informed simulations on top of existing EDC systems, it helps pharmaceutical and biotech teams optimize patient selection, reduce trial size, and generate defensible long‑term projections for pricing and reimbursement discussions.
Funding
Funding not disclosed
Founders
Product
Problem
Pharmaceutical companies and clinical research organizations often face lengthy, costly trials with uncertain outcomes due to suboptimal patient selection, limited ability to predict long‑term clinical and commercial performance, and reliance on manual data review processes.
Solution
Reveal Clinical, Oovacha’s AI‑driven platform, integrates internal trial data with published literature and real‑world evidence to create a unified dataset for simulation and forecasting. Using FDA‑ and EMA‑endorsed model‑informed drug development frameworks, the system runs virtual trial designs, quantifies trade‑offs, and projects subgroup‑level clinical outcomes and market value. The platform sits on top of existing EDC systems (e.g., Medidata Rave, Merative Zelta), requiring no data migration, and delivers defensible long‑term projections that can support pricing, reimbursement, and regulatory discussions. By enabling optimized patient enrichment and leaner trial designs, Reveal Clinical helps increase success rates, reduce trial size, and expand the addressable market at launch.
Target Audience
Primary customers are pharmaceutical R&D teams, biotech developers, and contract research organizations seeking to improve trial efficiency and market access for new therapies.
Features
- Data harmonization engine that merges internal trial data with literature and real‑world evidence
- AI‑powered simulation suite to evaluate alternative trial designs and patient enrichment strategies
- Subgroup‑level outcome forecasting for clinical efficacy, safety, and commercial value
- Seamless integration with major EDC platforms without replacing existing systems
- Compliance with HIPAA, 21 CFR Part 11, GAMP5, and GDPR for secure, audit‑ready data handling
- Interactive dashboards that visualize trade‑offs, long‑term projections, and pricing justification